• Home
  • Search Results
  • A critical role for interferon regulatory factor 9 in cerebral ischemic stroke.

A critical role for interferon regulatory factor 9 in cerebral ischemic stroke.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2014-09-05)
Hou-Zao Chen, Sen Guo, Zuo-Zhi Li, Yanyun Lu, Ding-Sheng Jiang, Ran Zhang, Hao Lei, Lu Gao, Xiaofei Zhang, Yan Zhang, Lang Wang, Li-Hua Zhu, Mei Xiang, Yan Zhou, Qi Wan, Hailong Dong, De-Pei Liu, Hongliang Li

The failure of past efforts to develop effective stroke treatments is at least partially because these treatments often interfered with essential physiological functions, even though they are targeted toward pathophysiological events, such as inflammation, excitotoxicity, and oxidative stress. Thus, the direct targeting of endogenous neuroprotective or destructive elements holds promise as a potential new approach to treating this devastating condition. Interferon regulatory factor 9 (IRF9), a transcription factor that regulates innate immune responses, has been implicated in neurological pathology. Here, we provide new evidence that IRF9 directly mediates neuronal death in male mice. In response to ischemia/reperfusion (I/R), IRF9 accumulated in neurons. IRF9 deficiency markedly mitigated both poststroke neuronal death and neurological deficits, whereas the neuron-specific overexpression of IRF9 sensitized neurons to death. The histone deacetylase Sirt1 was identified as a novel negative transcriptional target of IRF9 both in vivo and in vitro. IRF9 inhibits Sirt1 deacetylase activity, culminating in the acetylation and activation of p53-mediated cell death signaling. Importantly, both the genetic and pharmacological manipulation of Sirt1 effectively counteracted the pathophysiological effects of IRF9 on stroke outcome. These findings indicate that, rather than activating a delayed innate immune response, IRF9 directly activates neuronal death signaling pathways through the downregulation of Sirt1 deacetylase in response to acute I/R stress.

Product Number
Product Description

Fluorescein, for fluorescence, free acid
Fluorescein, European Pharmacopoeia (EP) Reference Standard
β-D-Allose, rare aldohexose sugar
Anti-NeuN Antibody, clone A60, clone A60, Chemicon®, from mouse
TriPure Isolation Reagent, solution (ready-to-use), pkg of 50 mL (11667157001), pkg of 200 mL (11667165001)
ApopTag Plus In Situ Apoptosis Fluorescein Detection Kit, The ApopTag Plus Fluorescein In Situ Apoptosis Detection Kit detects apoptotic cells in situ by the indirect TUNEL method, utilizing an anti-digoxigenin antibody that is conjugated to a fluorescein reporter molecule.
Anti-c-Myc antibody, Mouse monoclonal, clone 9E10, purified from hybridoma cell culture
Anti-c-Myc antibody produced in rabbit, ~0.5 mg/mL, affinity isolated antibody, buffered aqueous solution